JP2023554389A5 - - Google Patents

Info

Publication number
JP2023554389A5
JP2023554389A5 JP2023536372A JP2023536372A JP2023554389A5 JP 2023554389 A5 JP2023554389 A5 JP 2023554389A5 JP 2023536372 A JP2023536372 A JP 2023536372A JP 2023536372 A JP2023536372 A JP 2023536372A JP 2023554389 A5 JP2023554389 A5 JP 2023554389A5
Authority
JP
Japan
Prior art keywords
liters
cells
translocation
cell culture
suspension cell
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023536372A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023554389A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/063739 external-priority patent/WO2022133051A1/en
Publication of JP2023554389A publication Critical patent/JP2023554389A/ja
Publication of JP2023554389A5 publication Critical patent/JP2023554389A5/ja
Pending legal-status Critical Current

Links

JP2023536372A 2020-12-16 2021-12-16 組換えアデノ随伴ウイルスウイルス粒子を生成する方法 Pending JP2023554389A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202063126405P 2020-12-16 2020-12-16
US63/126,405 2020-12-16
PCT/US2021/063739 WO2022133051A1 (en) 2020-12-16 2021-12-16 Method of producing a recombinant adeno-associated virus particle

Publications (2)

Publication Number Publication Date
JP2023554389A JP2023554389A (ja) 2023-12-27
JP2023554389A5 true JP2023554389A5 (https=) 2024-12-23

Family

ID=80050899

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023536372A Pending JP2023554389A (ja) 2020-12-16 2021-12-16 組換えアデノ随伴ウイルスウイルス粒子を生成する方法

Country Status (10)

Country Link
US (1) US20240167054A1 (https=)
EP (1) EP4263841A1 (https=)
JP (1) JP2023554389A (https=)
KR (1) KR20230120128A (https=)
CN (1) CN116761892A (https=)
AU (1) AU2021403076A1 (https=)
CA (1) CA3201743A1 (https=)
IL (1) IL303614A (https=)
MX (1) MX2023007315A (https=)
WO (1) WO2022133051A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN116983434B (zh) * 2023-09-28 2024-03-15 康霖生物科技（杭州）有限公司 用于基因治疗的核酸构建体及其用途
WO2026083329A1 (en) 2024-10-18 2026-04-23 Precision Biosciences, Inc. Methods of nuclease-initiated homology directed repair and replacement and compositions and uses thereof
WO2026083328A1 (en) 2024-10-18 2026-04-23 Precision Biosciences, Inc. Base editing nucleotide sequences using homology directed repair

Family Cites Families (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6989264B2 (en) 1997-09-05 2006-01-24 Targeted Genetics Corporation Methods for generating high titer helper-free preparations of released recombinant AAV vectors
CA2379166C (en) 1999-08-09 2013-03-26 Targeted Genetics Corporation Enhancement of expression of a single-stranded, heterologous nucleotide sequence from recombinant viral vectors by designing the sequence such that it forms instrastrand base pairs
US6723551B2 (en) 2001-11-09 2004-04-20 The United States Of America As Represented By The Department Of Health And Human Services Production of adeno-associated virus in insect cells
MX359371B (es) 2001-11-13 2018-09-25 Univ Pennsylvania Un metodo para detectar y/o identificar secuencias del virus adeno-asociado y aislamiento de secuencias novedosas identificadas de ese modo.
PT1453547T (pt) 2001-12-17 2016-12-28 Univ Pennsylvania Sequências do vírus adeno-associado (aav) do serotipo 8, vetores contendo as mesmas, e utilizações destas
EP2345731B1 (en) 2003-09-30 2015-10-21 The Trustees of the University of Pennsylvania Adeno-associated virus (AAV) clades, sequences, vectors containing same, and uses thereof
US7183969B2 (en) 2004-12-22 2007-02-27 Raytheon Company System and technique for calibrating radar arrays
ES2525067T3 (es) 2005-04-07 2014-12-17 The Trustees Of The University Of Pennsylvania Método de incremento de la función de un vector de AAV
JP4495210B2 (ja) 2005-06-09 2010-06-30 パナソニック株式会社 振幅誤差補償装置及び直交度誤差補償装置
ES2751999T3 (es) 2008-01-29 2020-04-02 Applied Genetic Tech Corporation Producción recombinante de virus adeno-asociados usando células BHK en suspensión
JP2011512156A (ja) 2008-02-19 2011-04-21 アムステルダム モレキュラー セラピューティクス ビー．ブイ． 昆虫細胞におけるパルボウイルスｒｅｐ及びｃａｐタンパク質の発現の最適化
US20110212526A1 (en) * 2008-03-18 2011-09-01 National Tsing Hua University Method for producing recombinant adeno-associated virus
EP2425000B1 (en) 2009-04-30 2019-02-20 The Trustees Of The University Of Pennsylvania Compositions for targeting conducting airway cells comprising adeno-associated virus constructs
US8609392B2 (en) 2009-05-12 2013-12-17 Transgene S.A. Method for orthopoxvirus production and purification
US8734809B2 (en) 2009-05-28 2014-05-27 University Of Massachusetts AAV's and uses thereof
WO2011097447A2 (en) * 2010-02-04 2011-08-11 Neurologix, Inc. Production of recombinant virus
US8628966B2 (en) 2010-04-30 2014-01-14 City Of Hope CD34-derived recombinant adeno-associated vectors for stem cell transduction and systemic therapeutic gene transfer
US8927514B2 (en) 2010-04-30 2015-01-06 City Of Hope Recombinant adeno-associated vectors for targeted treatment
WO2012057363A1 (ja) 2010-10-27 2012-05-03 学校法人自治医科大学 神経系細胞への遺伝子導入のためのアデノ随伴ウイルスビリオン
WO2012109570A1 (en) 2011-02-10 2012-08-16 The University Of North Carolina At Chapel Hill Viral vectors with modified transduction profiles and methods of making and using the same
CN105755044A (zh) 2011-04-22 2016-07-13 加利福尼亚大学董事会 具有变异衣壳的腺相关病毒病毒体及其使用方法
ES2857773T5 (es) 2011-08-24 2024-06-04 Univ Leland Stanford Junior Nuevas proteínas de la cápside de AAV para la transferencia de ácidos nucleicos
WO2013170078A1 (en) 2012-05-09 2013-11-14 Oregon Health & Science University Adeno associated virus plasmids and vectors
CA2905952A1 (en) 2013-03-13 2014-10-02 The Children's Hospital Of Philadelphia Adeno-associated virus vectors and methods of use thereof
MX388221B (es) 2013-04-20 2025-03-19 Res Institute At Nationwide Children´S Hospital ADMINISTRACIÓN DE VIRUS ADENO-ASOCIADO RECOMBINANTE DE CONSTRUCCIONES DE POLINUCLÉOTIDOS U7snRNA DIRIGIDA AL EXÓN 2.
IL297919A (en) 2013-07-22 2023-01-01 Childrens Hospital Philadelphia Variant aav and compositions, methods and uses for gene transfer to cells, organs and tissues
ES2739288T3 (es) 2013-09-13 2020-01-30 California Inst Of Techn Recuperación selectiva
CN106232618A (zh) 2013-10-11 2016-12-14 马萨诸塞眼科耳科诊所 预测祖先病毒序列的方法及其用途
WO2015164757A1 (en) 2014-04-25 2015-10-29 Oregon Health & Science University Methods of viral neutralizing antibody epitope mapping
EP3151866B1 (en) 2014-06-09 2023-03-08 Voyager Therapeutics, Inc. Chimeric capsids
AU2015320694B2 (en) 2014-09-24 2021-11-11 City Of Hope Adeno-associated virus vector variants for high efficiency genome editing and methods thereof
JP6665466B2 (ja) 2015-09-26 2020-03-13 日亜化学工業株式会社 半導体発光素子及びその製造方法
WO2017070491A1 (en) 2015-10-23 2017-04-27 Applied Genetic Technologies Corporation Ophthalmic formulations
WO2018208960A1 (en) * 2017-05-09 2018-11-15 Dimension Therapeutics, Inc. Scalable method for producing transfection reagents
CA3098565A1 (en) 2018-04-29 2019-11-07 Claire G. ZHANG Scalable clarification process for recombinant aav production
WO2019212922A1 (en) 2018-04-29 2019-11-07 Regenxbio Inc. Systems and methods of spectrophotometry for the determination of genome content, capsid content and full/empty ratios of adeno-associated virus particles
US12070702B2 (en) 2018-06-14 2024-08-27 Regenxbio Inc. Anion exchange chromatography for recombinant AAV production
EP3833745A1 (en) 2018-08-10 2021-06-16 REGENXBIO Inc. Scalable method for recombinant aav production

Similar Documents

Publication Publication Date Title
JP2023554389A5 (https=)
El Andari et al. Production, processing, and characterization of synthetic AAV gene therapy vectors
Grieger et al. Production of recombinant adeno-associated virus vectors using suspension HEK293 cells and continuous harvest of vector from the culture media for GMP FIX and FLT1 clinical vector
Kotin Large-scale recombinant adeno-associated virus production
Florea et al. High-efficiency purification of divergent AAV serotypes using AAVX affinity chromatography
Varadi et al. Novel random peptide libraries displayed on AAV serotype 9 for selection of endothelial cell-directed gene transfer vectors
Kohlbrenner et al. Successful production of pseudotyped rAAV vectors using a modified baculovirus expression system
Govindasamy et al. Structurally mapping the diverse phenotype of adeno-associated virus serotype 4
Li et al. Production and characterization of novel recombinant adeno-associated virus replicative-form genomes: a eukaryotic source of DNA for gene transfer
EP3387118B1 (en) Scalable purification method for aavrh10
JP7601339B2 (ja) Ａａｖを産生する方法
EP1944362B1 (en) Methods for generating high titer helper-free preparations of recombinant AAV vectors
US20120220492A1 (en) Viral Vectors with Improved Properties
WO2003018820A2 (en) Mutant recombinant adeno-associated viruses related applications
US20240084268A1 (en) Method for purifying recombinant viral particles
CN116063404B (zh) 可提高AAV包装能力的衣壳蛋白MutD及其应用
Li et al. Bat adeno-associated viruses as gene therapy vectors with the potential to evade human neutralizing antibodies
Bowles et al. The genus dependovirus
Hewitt et al. Reducing the risk of adeno-associated virus (AAV) vector mobilization with AAV type 5 vectors
JP2024503895A5 (https=)
US12312606B2 (en) Nucleic acid constructs for VA RNA transcription
JP2019514375A (ja) イソメロヒドロラーゼをコードするウイルスベクターについての相対効力アッセイ
CN119546320A (zh) 用于生产重组aav颗粒的方法
CN116063405B (zh) 可提高AAV病毒包装能力的衣壳蛋白突变体MutC及其应用
US20230295608A1 (en) Methods for Characterization of Viral Genome Using Base Modifications